Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:CTLT

Catalent (CTLT) Stock Price, News & Analysis

Catalent logo

About Catalent Stock (NYSE:CTLT)

Key Stats

Today's Range
$63.48
$63.48
50-Day Range
$59.66
$63.48
52-Week Range
$58.28
$63.50
Volume
N/A
Average Volume
2.08 million shs
Market Capitalization
$11.52 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CTLT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Catalent and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CTLT Stock News Headlines

Nvidia CEO Makes First Ever Tesla Announcement
While headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $25 trillion AI revolution — one that Nvidia’s CEO himself has called a “multi-trillion-dollar future industry” — and he’s uncovered a little-known stock 168 times smaller than Nvidia that could be positioned to ride this breakthrough.tc pixel
Lisata Therapeutics signs research license with Catalent
See More Headlines

CTLT Stock Analysis - Frequently Asked Questions

Catalent, Inc. (NYSE:CTLT) released its earnings results on Tuesday, November, 5th. The company reported ($0.13) EPS for the quarter, missing analysts' consensus estimates of $0.05 by $0.18. The company's quarterly revenue was up 4.2% compared to the same quarter last year.

Based on aggregate information from My MarketBeat watchlists, some other companies that Catalent investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Tesla (TSLA), Netflix (NFLX), JPMorgan Chase & Co. (JPM) and Exxon Mobil (XOM).

Company Calendar

Last Earnings
11/05/2024
Today
10/02/2025
Fiscal Year End
6/30/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NYSE:CTLT
CIK
1596783
Employees
16,900
Year Founded
2007

Profitability

EPS (Trailing Twelve Months)
($2.26)
Trailing P/E Ratio
N/A
Forward P/E Ratio
81.38
P/E Growth
2.69
Net Income
-$1.04 billion
Net Margins
-9.28%
Pretax Margin
-7.83%
Return on Equity
-0.66%
Return on Assets
-0.24%

Debt

Debt-to-Equity Ratio
1.38
Current Ratio
2.51
Quick Ratio
1.96

Sales & Book Value

Annual Sales
$4.38 billion
Price / Sales
2.63
Cash Flow
$2.64 per share
Price / Cash Flow
24.04
Book Value
$19.91 per share
Price / Book
3.19

Miscellaneous

Outstanding Shares
181,510,000
Free Float
180,949,000
Market Cap
$11.52 billion
Optionable
Optionable
Beta
1.15

Social Links

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NYSE:CTLT) was last updated on 10/2/2025 by MarketBeat.com Staff
From Our Partners